Charles River Laboratories
251 Ballardvale Street
About Charles River Laboratories
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.
For more information, please visit www.criver.com.
Equal Employment Opportunity
Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet
448 articles about Charles River Laboratories
Charles River Laboratories To Present At UBS Healthcare Services Conference
Charles River Laboratories Announces Fourth-Quarter And Full-Year 2005 Results
Charles River Laboratories Appoints John C. Ho, M.D. As Senior Vice President, Corporate Strategy
Charles River Laboratories Becomes Deltagen's Exclusive, Worldwide Custodian, Supplier Of Knockout Mice Repository
Charles River Laboratories To Present At JPMorgan Healthcare Conference
Charles River Laboratories Provides Guidance For 2006 And Reaffirms Guidance For 2005
Charles River Laboratories Announces Third-Quarter 2005 Results
Charles River Laboratories Montreal Utilizes Vivometrics, Inc. LifeShirt In Groundbreaking Non-Invasive, Ambulatory, Respiratory And ECG Preclinical Studies